Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Salarius Pharmaceuticals Inc SLRX

Healthcare Biotechnology
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing treatments for parties with cancers in need of new treatment options. Its product portfolio includes seclidemstat, an oral novel small molecule inhibitor of the LSD1 enzyme and the Company's lead candidate, which is being studied as a potential treatment for pediatric cancers, sarcomas, and... see more

Recent & Breaking News (NDAQ:SLRX)

Flex Pharma to Report Second Quarter 2015 Results on August 5, 2015

Business Wire July 29, 2015

Flex Pharma Announces Two Poster Presentations at Upcoming Scientific Meetings

Business Wire July 28, 2015

Flex Pharma Announces Reduction of Muscle Cramping in Athletes

Business Wire July 7, 2015

Flex Pharma to Present at the Cantor Fitzgerald Inaugural Healthcare Conference

Business Wire July 1, 2015

Alfred Sandrock, Jr., M.D., Ph.D., Chief Medical Officer of Biogen, Joins Flex Pharma's Scientific Advisory Board

Business Wire June 15, 2015

Flex Pharma Presenting at Two Upcoming Consumer Investor Conferences in June 2015

Business Wire June 2, 2015

Flex Pharma to Ring the NASDAQ Stock Market Closing Bell

Business Wire June 1, 2015

Flex Pharma, Inc. (Nasdaq: FLKS) to Ring The Nasdaq Stock Market Closing Bell

GlobeNewswire May 29, 2015

Flex Pharma Presenting at Two Upcoming Healthcare Investor Conferences in June 2015

Business Wire May 28, 2015

Flex Pharma Reports First Quarter 2015 Financial Results

Business Wire May 6, 2015

NSF Approves Flex Pharma's Proprietary Formulation under NSF's Certified for Sport® Program

Business Wire May 4, 2015

Flex Pharma to Report First Quarter 2015 Results on May 6, 2015

Business Wire April 29, 2015

Flex Pharma Initiates Human Proof-of-Concept Efficacy Study in Nocturnal Leg Cramps

Business Wire April 27, 2015

Flex Pharma Data Presented at AAN Platform Session

Business Wire April 21, 2015

John Winkelman, M.D., Ph.D., Joins Flex Pharma's Scientific Advisory Board

Business Wire April 13, 2015

Jeffrey D. Capello Appointed to Flex Pharma's Board of Directors

Business Wire April 6, 2015

Flex Pharma Added to Russell 3000®, Russell 2000®, and Russell Microcap® Indices

Business Wire April 1, 2015

Flex Pharma Reports Year End 2014 Financial Results

Business Wire March 17, 2015

Thomas Wessel, M.D., Ph.D., Appointed Chief Medical Officer

Business Wire March 16, 2015

Flex Pharma to Report Full Year 2014 Results on March 17, 2015

Business Wire March 10, 2015